114 related articles for article (PubMed ID: 9918760)
1. Effect of endothelin receptor antagonists (BQ-485, Ro 47-0203) on collagen deposition during the development of bleomycin-induced pulmonary fibrosis in rats.
Mutsaers SE; Marshall RP; Goldsack NR; Laurent GJ; McAnulty RJ
Pulm Pharmacol Ther; 1998; 11(2-3):221-5. PubMed ID: 9918760
[TBL] [Abstract][Full Text] [Related]
2. Increased endothelin-1 and its localization during the development of bleomycin-induced pulmonary fibrosis in rats.
Mutsaers SE; Foster ML; Chambers RC; Laurent GJ; McAnulty RJ
Am J Respir Cell Mol Biol; 1998 May; 18(5):611-9. PubMed ID: 9569231
[TBL] [Abstract][Full Text] [Related]
3. Highly Selective Endothelin-1 Receptor A Inhibition Prevents Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice.
Manitsopoulos N; Nikitopoulou I; Maniatis NA; Magkou C; Kotanidou A; Orfanos SE
Respiration; 2018; 95(2):122-136. PubMed ID: 29131071
[TBL] [Abstract][Full Text] [Related]
4. Increased endothelin-1 in bleomycin-induced pulmonary fibrosis and the effect of an endothelin receptor antagonist.
Park SH; Saleh D; Giaid A; Michel RP
Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 1):600-8. PubMed ID: 9279246
[TBL] [Abstract][Full Text] [Related]
5. Effect of leukotriene receptor antagonists on lung fibrosis in rats.
Shaker OG; Sourour DA
J Appl Toxicol; 2011 Oct; 31(7):678-84. PubMed ID: 21381050
[TBL] [Abstract][Full Text] [Related]
6. Improvement of bleomycin-induced pulmonary hypertension and pulmonary fibrosis by the endothelin receptor antagonist Bosentan.
Schroll S; Arzt M; Sebah D; Nüchterlein M; Blumberg F; Pfeifer M
Respir Physiol Neurobiol; 2010 Jan; 170(1):32-6. PubMed ID: 19931426
[TBL] [Abstract][Full Text] [Related]
7. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis.
Keane MP; Belperio JA; Moore TA; Moore BB; Arenberg DA; Smith RE; Burdick MD; Kunkel SL; Strieter RM
J Immunol; 1999 May; 162(9):5511-8. PubMed ID: 10228032
[TBL] [Abstract][Full Text] [Related]
8. Role of thrombin and its major cellular receptor, protease-activated receptor-1, in pulmonary fibrosis.
Howell DC; Laurent GJ; Chambers RC
Biochem Soc Trans; 2002 Apr; 30(2):211-6. PubMed ID: 12023853
[TBL] [Abstract][Full Text] [Related]
9. Gender-based differences in bleomycin-induced pulmonary fibrosis.
Gharaee-Kermani M; Hatano K; Nozaki Y; Phan SH
Am J Pathol; 2005 Jun; 166(6):1593-606. PubMed ID: 15920145
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of bleomycin-induced lung fibrosis in rats by mesna.
El-Medany A; Hagar HH; Moursi M; At Muhammed R; El-Rakhawy FI; El-Medany G
Eur J Pharmacol; 2005 Feb; 509(1):61-70. PubMed ID: 15713430
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the inhibitory potential of sulindac against the bleomycin-induced pulmonary fibrosis in wistar rats.
Verma R; Brahmankar M; Kushwah L; Suresh B
Environ Toxicol Pharmacol; 2013 Nov; 36(3):769-78. PubMed ID: 23958969
[TBL] [Abstract][Full Text] [Related]
12. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
13. Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF-β activation: a biphasic experimental study.
Chitra P; Saiprasad G; Manikandan R; Sudhandiran G
Toxicol Lett; 2013 May; 219(2):178-93. PubMed ID: 23523906
[TBL] [Abstract][Full Text] [Related]
14. [Losartan in the rat model of bleomycin-induced pulmonary fibrosis and its impact on the expression of monocyte chemoattractant protein-1 and basic fibroblast growth factor].
Fang X; Zhu Y; Hu X; Liu Y
Zhonghua Jie He He Hu Xi Za Zhi; 2002 May; 25(5):268-72. PubMed ID: 12133317
[TBL] [Abstract][Full Text] [Related]
15. Targeting protease activated receptor-1 with P1pal-12 limits bleomycin-induced pulmonary fibrosis.
Lin C; Duitman J; Daalhuisen J; Ten Brink M; von der Thüsen J; van der Poll T; Borensztajn K; Spek CA
Thorax; 2014 Feb; 69(2):152-60. PubMed ID: 24029744
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of bleomycin-induced pulmonary fibrosis by lipopolysaccharide.
Phan SH; Fantone JC
Lab Invest; 1984 May; 50(5):587-91. PubMed ID: 6201676
[TBL] [Abstract][Full Text] [Related]
17. The antifibrotic effects of alveolar macrophages 5-HT2C receptors blockade on bleomycin-induced pulmonary fibrosis in rats.
Elaidy SM; Essawy SS
Pharmacol Rep; 2016 Dec; 68(6):1244-1253. PubMed ID: 27686964
[TBL] [Abstract][Full Text] [Related]
18. Bleomycin-induced pulmonary fibrosis is independent of eosinophils.
Hao H; Cohen DA; Jennings CD; Bryson JS; Kaplan AM
J Leukoc Biol; 2000 Oct; 68(4):515-21. PubMed ID: 11037973
[TBL] [Abstract][Full Text] [Related]
19. Localization of endothelin receptors in bleomycin-induced pulmonary fibrosis in the rat.
Wendel M; Petzold A; Koslowski R; Kasper M; Augstein A; Knels L; Bleyl JU; Koch T
Histochem Cell Biol; 2004 Nov; 122(5):507-17. PubMed ID: 15480737
[TBL] [Abstract][Full Text] [Related]
20. Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis.
Serrano-Mollar A; Nacher M; Gay-Jordi G; Closa D; Xaubet A; Bulbena O
Am J Respir Crit Care Med; 2007 Dec; 176(12):1261-8. PubMed ID: 17641155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
